Dino C. Miano
InvestorSenior Vice President, CMC and Technical Operations at Avalo Therapeutics
About
Over 25 years of pharmaceutical development experience in analytical chemistry and product development. Previously Executive Director at Alexion leading analytical and pharmaceutical development groups supporting development and commercialization of multiple rare disease therapies including Soliris, Strensiq, Kanuma, and Ultomiris.
Colleagues at Avalo Therapeutics
Aaron Kantoff
Board Member at Avalo Therapeutics
Ashley Ivanowicz
Senior Vice President, Human Resources at Avalo Therapeutics
Chris Sullivan
Chief Financial Officer at Avalo Therapeutics
Colleen Matkowski
Senior Vice President, Global Regulatory Affairs and Quality Assurance at Avalo Therapeutics
Garry A. Neil
Chief Executive Officer at Avalo Therapeutics
Gilla Kaplan
Board Member at Avalo Therapeutics
Jennifer Riley
Chief Strategy Officer at Avalo Therapeutics
Kathleen Cohen
Senior Vice President, Clinical Development Operations at Avalo Therapeutics